Photoimmunotherapy

Near-infrared Photoimmunotherapy Targeting Canine Mammary Tumors: Comparative Oncology for Overcoming Human Breast Cancer

Published in: Anticancer Research Authors: Motofumi Suzuki, Aki Furusawa, Hiroshi Yamamoto, Ko Kitamura, Makoto Kano, Miyu Kano, Seiichiro Takao, Yukinari Kato, Amy K. Leblanc, Peter L. Choyke, Hisataka Kobayashi    

Near-infrared Photoimmunotherapy Targeting Canine Mammary Tumors: Comparative Oncology for Overcoming Human Breast Cancer Read More »

Understanding Tumor Microenvironment Dynamics and Immune Checkpoint Inhibitor Efficacy Following mEGFR-Targeted Near-Infrared Photoimmunotherapy

Published in: Cancer Letters Authors: Seiichiro Takao, Aki Furusawa, Makoto Kano, Hiroshi Yamamoto, Miyu Kano, Motofumi Suzuki, Hiroshi Fukushima, Shuhei Okuyama, Ko Kitamura, Peter L. Choyke, Hisataka Kobayashi    

Understanding Tumor Microenvironment Dynamics and Immune Checkpoint Inhibitor Efficacy Following mEGFR-Targeted Near-Infrared Photoimmunotherapy Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – June 2026

Research teams led by Dr. Timothy Baran and Dr. Nicole Wilson investigated laser-activated methylene blue therapy for perforated appendicitis. Using the ML7710 laser system, the study demonstrated a feasible and safe resistance-independent antimicrobial treatment approach.

Modulight Spotlights: LASER-SHARP RESEARCH – June 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – May 2026

Modulight Spotlights: LASER-SHARP RESEARCH – May 2026 The research spotlight goes this month to Nimit Shah and the team from Dr. Girgis Obaid’s Lab Molecular Imaging and Optical Nanotherapeutics at University of Texas, Dallas. They developed and evaluated light-activated, verteporfin-containing liposomes for pancreatic cancer. This cancer is notoriously difficult to treat and more effective therapies are

Modulight Spotlights: LASER-SHARP RESEARCH – May 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – April 2026

Modulight Spotlights: LASER-SHARP RESEARCH – April 2026 This month we are pleased to highlight new interesting article by Naoya Kondo and the team at Kansai Medical University in Japan. They developed a cancer cell-targeted photoimmunotherapy compound consisting of IR700 photoabsorber conjugated to bicyclic peptide. Use of small peptide could speed drug clearance from the body

Modulight Spotlights: LASER-SHARP RESEARCH – April 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – March 2026

Modulight Spotlights: LASER-SHARP RESEARCH – March 2026 The development of chemoresistance presents a major challenge in treating peritoneal metastasis, which often occurs in advanced ovarian cancer. To tackle this, Kaitlyn Moore and teams at University of Maryland and National Cancer Institute evaluated photoimmunotherapy as a solution to inhibit a drug efflux pump on cancer cells

Modulight Spotlights: LASER-SHARP RESEARCH – March 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – February 2026

Modulight Spotlights: LASER-SHARP RESEARCH – February 2026 This month, we are highlighting promising work by Professor Hirofumi Hanaoka’s team at Kansai Medical University, Photo-ImmunoTherapy Research Institute. They developed a novel peptide-based photoimmunotherapy drug that targets PD-L1, which is expressed on many types of cancer cells. Preclinical experiments showed significant suppression of tumor growth and an

Modulight Spotlights: LASER-SHARP RESEARCH – February 2026 Read More »

Modulight Spotlights: LASER-SHARP RESEARCH – January 2026

Modulight Spotlights: LASER-SHARP RESEARCH – January 2026 The highlight of the month goes to teams of researchers led by Prof. Imran Rizvi at University of North Carolina at Chapel Hill. Their latest publication shows that certain light-activated therapy with BPD photosensitizer and ML6600 laser can induce ferroptosis-like cell death, including formation of lipid peroxides, in

Modulight Spotlights: LASER-SHARP RESEARCH – January 2026 Read More »

Scroll to Top